Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | FTO | Q9C0B1 | 8/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.60 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.60 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1228265 | 0.88 | ALDH1A1 (0.68) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL29044412 | 0.86 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL4056456 | 0.84 | FTO (0.62) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL3189664 | 0.84 | FTO (0.66) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL4452146 | 0.84 | FTO (0.70) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL1908131 | 0.79 | HPGD (0.63) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL6662140 | 0.79 | FTO (0.74) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL139173 | 0.79 | FTO (0.65) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL1420534 | 0.79 | FTO (0.70) | ALDH1A1HPGDALOX12CYP2C9ALOX15 | |
| SCHEMBL14056898 | 0.78 | HPGD (0.80) | ALDH1A1HPGDALOX12CYP2C9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2459229-B1 | USE OF CONSTRAINED DIPEPTIDE AND TRIPEPTIDE MIMIC OLIGOMERS AS VECTORIZATION AGENTS | CENTRE NATIONAL DE LA RECHERCHE SCIENT (C N R S ) (FR) | 2018-02-28 | — | — | EP | claimed |
| US-9061069-B2 | Use of constrained peptide mimic oligomers as vectorization agents | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-06-23 | — | — | US | claimed |
| US-20240024240-A1 | A NANOPARTICLE MATERIAL, A PROCESS FOR OBTAINING THE NANOPARTICLE MATERIAL, A PRODUCT COMPRISING THE NANOPARTICLE MATERIAL AND USES THEREOF | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2024-01-25 | — | — | US | disclosed |
| EP-4135886-A1 | A NANOPARTICLE MATERIAL, A PROCESS FOR OBTAINING THE NANOPARTICLE MATERIAL, A PRODUCT COMPRISING THE NANOPARTICLE MATERIAL AND USES THEREOF | B. Braun Surgical, S.A. (ES) | 2023-02-22 | — | — | EP | disclosed |
| CN-115624025-A | Polyacrylic acid modified Mn 3 O 4 Application of nano-particles in improving high-temperature resistance of crops | 华中农业大学 | 2023-01-20 | — | — | CN | disclosed |
| US-11299590-B2 | Process for preparation of bioorganic nylon polymers and their use as antibacterial material | UNIVERSITE DE MONTPELLIER | 2022-04-12 | — | — | US | disclosed |
| US-20210393855-A1 | NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME | UNIVERSITE DE MONTPELLIER (FR) | 2021-12-23 | — | — | US | disclosed |
| CN-108495882-B | Preparation method of bio-organic nylon polymer and application of bio-organic nylon polymer as antibacterial material | 蒙彼利埃大学 | 2021-11-16 | — | — | CN | disclosed |
| WO-2021209511-A1 | A NANOPARTICLE MATERIAL, A PROCESS FOR OBTAINING THE NANOPARTICLE MATERIAL, A PRODUCT COMPRISING THE NANOPARTICLE MATERIAL AND USES THEREOF | B. BRAUN SURGICAL S.A. (ES) | 2021-10-21 | — | — | WO | disclosed |
| CN-113171470-A | Aggregation-induced emission molecule-phage bioconjugate | 香港科技大学 | 2021-07-27 | — | — | CN | disclosed |
| EP-3320342-B1 | NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME | UNIV MONTPELLIER (FR) | 2021-03-03 | — | — | EP | disclosed |
| US-20110251404-A1 | REAGENT FOR MEASUREMENT OF ACTIVE OXYGEN | THE UNIVERSITY OF TOKYO (JP) | 2011-10-13 | — | — | US | disclosed |
| US-20110081298-A1 | RATIOMETRIC BIOLUMINESCENT SENSOR FOR IMAGINING OXIDATIVE STRESS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2011-04-07 | — | — | US | disclosed |
| WO-2011012729-A1 | USE OF CONSTRAINED DIPEPTIDE AND TRIPEPTIDE MIMIC OLIGOMERS AS VECTORIZATION AGENTS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2011-02-03 | — | — | WO | disclosed |
| US-20100047859-A1 | SILICA-BASED FLUORESCENT NANOPARTICLES | SNU R&DB FOUNDATION (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20080262349-A1 | Ultrasonic Cancer Treatment Enhancer and Cell Killer | TOTO LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1834646-A1 | ULTRASONIC CANCER THERAPY ACCELERATOR AND CYTOTOXIC AGENT | TOTO LTD. (JP) | 2007-09-19 | — | — | EP | disclosed |
| WO-2007088446-A2 | A PROCESS AND A REAGENT KIT FOR THE EXAMINATION OF THE METABOLIC STATE RELATED TO THE CARBOHYDRATE AND LIPID METABOLISM OF A HUMAN ORGANISM | N-GENE RESEARCH LABORATORIES INC. (US) | 2007-08-09 | — | — | WO | disclosed |
| US-20060025335-A1 | Netrin compositions and methods of using the same | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2006-02-02 | — | — | US | disclosed |
| WO-2005074556-A2 | NETRIN COMPOSITIONS AND METHODS OF USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251404-A1 | REAGENT FOR MEASUREMENT OF ACTIVE OXYGEN | CBR1, CBR3, HAO2 | ALDH1A1 321/4885HPGD 20/4885ALOX12 396/4885 |
| US-20100047859-A1 | SILICA-BASED FLUORESCENT NANOPARTICLES | NOXO1, NOX3, SOS1 | ALDH1A1 1247/4885HPGD 3258/4885ALOX12 667/4885 |
| US-20210393855-A1 | NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME | ILK, CD44, VCL | ALDH1A1 877/4885HPGD 1474/4885ALOX12 2925/4885 |
| US-11299590-B2 | Process for preparation of bioorganic nylon polymers and their use as antibacterial material | DDC, PDCD2L, PCBP1 | ALDH1A1 4753/4885HPGD 4010/4885ALOX12 3791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.